
ADVERTISEMENT

Hansa Medical, Lund-based developer of novel immunomodulatory enzymes, has recruited Sam Agus as Chief Medical Officer. Agus joins from H. Lundbeck AS, where he was Chief Specialist, Medical Affairs Neurology.
Agus is a board-certified neurologist; his therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases. He has previously held leading positions at several pharmaceutical companies, including Shire, Solvay Pharmaceuticals and Abbott Laboratories.
© european biotechnology | 11 April 2017 |
YOU MIGHT ALSO LIKE
YOU DON`T WANT TO MISS ANYTHING?
Sign up for our newsletter!